Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients

计划入组 100 人 · 首次发布于 2015 年 9 月 11 日

Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma

计划入组 80 人 · 首次发布于 2021 年 7 月 16 日

Modulation of Fibrosis-inducing Pathways in Acute Myocardial Infarction

计划入组 50 人 · 首次发布于 2021 年 11 月 17 日

beta-catenin modulator

Beta-catenin Inhibitor (PhaseRx)

beta-catenin degrader (cancer)

Beta Bionics

Beta Innov

France

K-Group Beta, Inc.

United States

Dewpoint Therapeutics Initiates First-in-Human Trial of Novel Beta-Catenin Condensate Modulator DPTX3186

Parabolus Medicines' zolocatetide posts 74% response rate in desmoid tumors, targeting the undruggable beta-catenin/TCF complex

Cytovation Secures $6M Funding to Advance CY-101 Cancer Therapy into Phase II Trials